Показати скорочений опис матеріалу
dc.contributor.author | Chympoy, K.A. | |
dc.contributor.author | Pashkovska, N.V. | |
dc.contributor.author | Fediv, O.I. | |
dc.contributor.author | Pavlibroda, N.M. | |
dc.date.accessioned | 2016-05-26T09:35:39Z | |
dc.date.available | 2016-05-26T09:35:39Z | |
dc.date.issued | 2014 | |
dc.identifier.uri | http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/10884 | |
dc.description.abstract | The dynamics of the indices of fibrinolysis and cellular adhesion in patients with chronic diffuse liver diseases against the ground of administration of “Triovit”, a selenium-containing drug, has been studied. The administration of “Triovit” in a comprehensive therapy of patients with chronic diffuse liver diseases was found to improve the indices of the blood plasma fibrinolytic system, to reduce adhesive cellular properties and to increase total enzymatic activity of the blood plasma. | ru_RU |
dc.language.iso | en | ru_RU |
dc.publisher | Буковинський медичний вісник. – 2014. – Т.18, №2(70). – C.113-116. | ru_RU |
dc.subject | chronic diffuse liver diseases | ru_RU |
dc.subject | cellular adhesion | ru_RU |
dc.subject | fibrinolysis | ru_RU |
dc.subject | Triovit | ru_RU |
dc.subject | хронические диффузные заболевания печени | ru_RU |
dc.subject | тиреоидный гомеостаз | ru_RU |
dc.subject | клеточная адгезия | ru_RU |
dc.subject | фибринолиз | ru_RU |
dc.subject | триовит | ru_RU |
dc.subject | thyroid homeostasis | ru_RU |
dc.subject | хронічні дифузні захворювання печінки | ru_RU |
dc.subject | тиреоїдний гомеостаз | ru_RU |
dc.subject | клітинна адгезія | ru_RU |
dc.subject | фібриноліз | ru_RU |
dc.subject | триовіт | ru_RU |
dc.title | Pathogenetic substantiation to correct disorders of the blood plasma fibrinolytic system in patients with chronic diffuse liverdiseases and disorders of thyroid homeostasis | ru_RU |
dc.type | Article | ru_RU |